BioHealth Innovation, Inc. (BHI) congratulates Prashant Panchal, MS, MBA, a member of the BHI Board of Directors, on his recent promotion at AstraZeneca from Director to Senior Director. His new business title is Head of Portfolio, Capacity and Business Operations.
In this role, Panchal’s scope is focused on the Biopharmaceutical Development department within Biopharma R&D. The team supports all biologics projects, helping advance the planning, operations, and coordination needed to move complex programs forward across AstraZeneca’s biologics portfolio.
“I’m excited to step into this new role and grateful for the opportunity to lead Portfolio, Capacity, and Business Operations for Biopharmaceutical Development at AstraZeneca. This is a tremendous opportunity to continue supporting our world-class scientists and engineers as we advance a complex biologics portfolio, deliver innovative therapies that make a meaningful difference for patients, and contribute to the local life sciences ecosystem.”
Panchal brings a strong combination of scientific training, business strategy, and operational leadership to his work. Prior to this promotion, he served as Director of Business Planning and Operations at AstraZeneca, where he oversaw capacity planning, capital expenditure, contracting, portfolio management, and governance for a department of more than 1,100 employees supporting over 100 drug programs.
His career has included roles across several leading biopharmaceutical organizations, including Eisai Pharmaceuticals, Teva Biopharmaceuticals USA, and AGC Biologics, one of the sector’s largest contract manufacturers. This experience has given him a broad view of drug development, manufacturing, business planning, and the operational needs of growing biopharma organizations.
Beyond his role at AstraZeneca, Panchal has been an active contributor to the region’s biohealth ecosystem. As a member of the BHI Board of Directors, he supports the organization’s mission to accelerate the commercialization of biohealth technologies and strengthen the BioHealth Capital Region. He also serves on the board of the Pinkney Innovation Complex for Science and Technology at Montgomery College (PIC MC), advancing workforce development, industry-academic collaboration, and early-career mentorship. In addition, he serves on the board of the Montgomery County Economic Development Corporation (MCEDC), where he brings a life sciences industry and business perspective to support economic growth across the county.
Panchal holds a Bachelor of Science in Biological Sciences with a focus in Cell Biology and Molecular Genetics from the University of Maryland, along with a Master of Science in Biotechnology Management and an MBA from the University of Maryland Global Campus.
BHI congratulates Prashant on this well-earned promotion and looks forward to his continued leadership and contributions to the region’s growing biohealth community.
In this episode of BioTalk with Rich Bendis, Jared Smith, MBA, CEcD, President and CEO of the Montgomery County Economic Development Corporation, joins the conversation to discuss his new role leading economic development efforts in one of the nation’s most important biohealth markets.